BVAN08 enhances radiosensitivity via downregulation of DNA-PKcs towards hepatic tumor xenograft
BVAN08 enhances radiosensitivity via downregulation of DNA-PKcs towards hepatic tumor xenograft
复制标题
DOI:
10.1016/j.radmp.2020.08.002
复制
发表时间:
2020-08
期刊:
影响因子:
--
通讯作者:
Bo Zhang;Lantao Liu;Sai Hu;Zi-jian Yu;Dafei Xie;P. Zhou
中科院分区:
文献类型:
--
作者:
Bo Zhang;Lantao Liu;Sai Hu;Zi-jian Yu;Dafei Xie;P. Zhou
Objective:To study the effects of the novel vanillin derivative BVAN08 on the radiosensitivity of hepatic cancer cells for the purpose of providing evidence for its potential use as a potential radiosensitive drug.Methods:Hepatic cancer Huh-7 cells labeled with luciferase were used to investigate the radiosensitivity induced by BVAN08in vivo. Colony formation assays and flow cytometry were used to measure the apoptosis and radiosensitivity of Huh-7 cellsin vitroproduced by BVAN08. Histology and immunohistochemistry were used to evaluate the toxicity of BVAN08in vivo.Results:BVAN08 induced apoptosis and cell cycle arrest of Huh-7 cells in a time-dependent manner. Moreover, BVAN08 combined with radiation increased the sensitivity of Huh-7 cells to γ-ray radiation and significantly inhibited tumor growthin vivo. The tumor inhibition rates of the BVAN08 treatment group, irradiation treatment group, and combined therapy group were 58%, 38%, and 85%, respectively. The DNA-PKcs expression in tumor tissues of the BVAN08 treatment group was lower than that of the control group (P< 0.01). BVAN08 inhibited the growth of Huh-7 cells in nude mice bearing tumors, without resulting in any noticeable side effects on bodyweight, livers, hearts, kidneys, or the number of peripheral white blood cells.Conclusions:As a natural food additive derivative, BVAN08 possesses the potential to be used as an effective anticancer drug to increase cell sensitivity to radiotherapy.